IRIS Accounts Production v23.4.0.336 09486791 director 1.4.22 31.3.23 31.3.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh094867912022-03-31094867912023-03-31094867912022-04-012023-03-31094867912021-03-31094867912021-04-012022-03-31094867912022-03-3109486791ns15:EnglandWales2022-04-012023-03-3109486791ns14:PoundSterling2022-04-012023-03-3109486791ns10:Director12022-04-012023-03-3109486791ns10:PrivateLimitedCompanyLtd2022-04-012023-03-3109486791ns10:SmallEntities2022-04-012023-03-3109486791ns10:AuditExempt-NoAccountantsReport2022-04-012023-03-3109486791ns10:SmallCompaniesRegimeForDirectorsReport2022-04-012023-03-3109486791ns10:SmallCompaniesRegimeForAccounts2022-04-012023-03-3109486791ns10:FullAccounts2022-04-012023-03-3109486791ns10:RegisteredOffice2022-04-012023-03-3109486791ns5:CurrentFinancialInstruments2023-03-3109486791ns5:CurrentFinancialInstruments2022-03-3109486791ns5:Non-currentFinancialInstruments2023-03-3109486791ns5:Non-currentFinancialInstruments2022-03-3109486791ns5:ShareCapital2023-03-3109486791ns5:ShareCapital2022-03-3109486791ns5:RetainedEarningsAccumulatedLosses2023-03-3109486791ns5:RetainedEarningsAccumulatedLosses2022-03-3109486791ns5:ComputerEquipment2022-04-012023-03-3109486791ns5:ComputerEquipment2022-03-3109486791ns5:ComputerEquipment2023-03-3109486791ns5:ComputerEquipment2022-03-3109486791ns5:CurrentFinancialInstrumentsns5:WithinOneYear2023-03-3109486791ns5:CurrentFinancialInstrumentsns5:WithinOneYear2022-03-3109486791ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2023-03-3109486791ns5:Non-currentFinancialInstrumentsns5:BetweenTwoFiveYears2022-03-31094867911ns10:Director12022-03-31094867911ns10:Director12021-03-31094867911ns10:Director12022-04-012023-03-31094867911ns10:Director12021-04-012022-03-31094867911ns10:Director12023-03-31094867911ns10:Director12022-03-31
REGISTERED NUMBER: 09486791 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 March 2023

for

C2C Healthcare Limited

C2C Healthcare Limited (Registered number: 09486791)






Contents of the Financial Statements
for the Year Ended 31 March 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


C2C Healthcare Limited

Company Information
for the Year Ended 31 March 2023







DIRECTOR: I T Matibiri





REGISTERED OFFICE: 50 Pomeroy Grove
Bushmead
Luton
Bedfordshire
LU2 7SY





REGISTERED NUMBER: 09486791 (England and Wales)





ACCOUNTANTS: ABC Accounting Services
1 Willoughton Place
Wharton Close
Gainsborough
Lincolnshire
DN21 1EB

C2C Healthcare Limited (Registered number: 09486791)

Balance Sheet
31 March 2023

31.3.23 31.3.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 1 1

CURRENT ASSETS
Debtors 5 3,023 246
Cash at bank and in hand 2,800 1,550
5,823 1,796
CREDITORS
Amounts falling due within one year 6 2,386 4,100
NET CURRENT ASSETS/(LIABILITIES) 3,437 (2,304 )
TOTAL ASSETS LESS CURRENT
LIABILITIES

3,438

(2,303

)

CREDITORS
Amounts falling due after more than one
year

7

8,558

6,167
NET LIABILITIES (5,120 ) (8,470 )

CAPITAL AND RESERVES
Called up share capital 1 1
Retained earnings (5,121 ) (8,471 )
SHAREHOLDERS' FUNDS (5,120 ) (8,470 )

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 March 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 March 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

C2C Healthcare Limited (Registered number: 09486791)

Balance Sheet - continued
31 March 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 15 March 2024 and were signed by:





I T Matibiri - Director


C2C Healthcare Limited (Registered number: 09486791)

Notes to the Financial Statements
for the Year Ended 31 March 2023

1. STATUTORY INFORMATION

C2C Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
Although the company has net liabilities at the year end, the director has confirmed his willingness to continue to support the company financially. As there is every indication that the company will continue to trade for the foreseeable future the accounts have been prepared on a going concern basis.

Turnover
Turnover represents amounts received for nursing and managerial services.The company is not registered for value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Computer equipment - 33% on cost

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.No provision was required at the year end date.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 1 (2022 - 1 ) .

4. TANGIBLE FIXED ASSETS
Computer
equipment
£   
COST
At 1 April 2022
and 31 March 2023 950
DEPRECIATION
At 1 April 2022
and 31 March 2023 949
NET BOOK VALUE
At 31 March 2023 1
At 31 March 2022 1

C2C Healthcare Limited (Registered number: 09486791)

Notes to the Financial Statements - continued
for the Year Ended 31 March 2023

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Trade debtors 1,027 -
Tax 1,996 246
3,023 246

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.23 31.3.22
£    £   
Bank loans and overdrafts 1,000 3,500
Tax 786 -
Accrued expenses 600 600
2,386 4,100

7. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR
31.3.23 31.3.22
£    £   
Bank loans - 2-5 years 8,558 6,167

8. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the years ended 31 March 2023 and 31 March 2022:

31.3.23 31.3.22
£    £   
I T Matibiri
Balance outstanding at start of year - 9,737
Amounts repaid - (9,737 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year - -

9. ULTIMATE CONTROLLING PARTY

The controlling party is I T Matibiri.